Evidence map›Paper›PMID 39847587›Full record

ArticlePLoS biology2025

DECODE enables high-throughput mapping of antibody epitopes at single amino acid resolution.

Katsuhiko Matsumoto, Shoko Y Harada, Shota Y Yoshida, Ryohei Narumi, Tomoki T Mitani, Saori Yada, Aya Sato, Eiichi Morii, Yoshihiro Shimizu, Hiroki R Ueda

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katsuhiko MatsumotoLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Shoko Y HaradaLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Shota Y YoshidaLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Ryohei NarumiLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Tomoki T MitaniLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Saori YadaDepartment of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Aya SatoLaboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Eiichi MoriiDepartment of Pathology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yoshihiro ShimizuLaboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.
Hiroki R UedaLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.ORCID 0000-0001-8342-9176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are extensively used in biomedical research, clinical fields, and disease treatment. However, to enhance the reproducibility and reliability of antibody-based experiments, it is crucial to have a detailed understanding of the antibody's target specificity and epitope. In this study, we developed a high-throughput and precise epitope analysis method, DECODE (Decoding Epitope Composition by Optimized-mRNA-display, Data analysis, and Expression sequencing). This method allowed identifying patterns of epitopes recognized by monoclonal or polyclonal antibodies at single amino acid resolution and predicted cross-reactivity against the entire protein database. By applying the obtained epitope information, it has become possible to develop a new 3D immunostaining method that increases the penetration of antibodies deep into tissues. Furthermore, to demonstrate the applicability of DECODE to more complex blood antibodies, we performed epitope analysis using serum antibodies from mice with experimental autoimmune encephalomyelitis (EAE). As a result, we were able to successfully identify an epitope that matched the sequence of the peptide inducing the disease model without relying on existing antigen information. These results demonstrate that DECODE can provide high-quality epitope information, improve the reproducibility of antibody-dependent experiments, diagnostics and therapeutics, and contribute to discover pathogenic epitopes from antibodies in the blood.

Indexed as

AntibodiesEpitope MappingEpitopesAmino AcidsAmino Acid SequenceAnimalsAntibodies, MonoclonalCross ReactionsEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMiceMice, Inbred C57BLReproducibility of ResultsAmino AcidsAntibodiesAntibodies, MonoclonalEpitopes

Identifiers

PMID39847587
PMCPMC11756784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.